Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Microorganisms in the gut influence how the body responds to common cancer treatments, including immunotherapy.
Researchers explore the relationship between gut bacteria and the body’s response to CAR-T therapy.
Over the past 20 years, Dr. Sears has conducted research on colonic microbiota and colon cancer, making her an expert in this field.
Study findings have implications for both diagnosis and prevention—and even for treatment.
At Melanoma Research Alliance’s 2021 Scientific Treat, scientists discussed enhancing anti-tumor immune response of combination therapies.
Altering gut bacteria may help overcome resistance to checkpoint inhibitors in people with melanoma and other cancers.
Metastatic kidney cancer patients with greater microbial diversity had better outcomes with immunotherapy.
There’s a lot of evidence that nutrition is now a central cog in the AhR signaling system and that can alter our biology in different ways.
Glucosinolates, the same small molecules that give broccoli its flavor, have also been associated with decreased risk of certain cancers.
Men who ate yogurt at least twice a week were 26% less likely to have polyps with the potential to become malignant.
Transforming the more common type A blood into type O could build up blood supplies and reduce shortages around the globe.
Changing gut bacteria to improve treatment response may be the next frontier in immunotherapy.
From immunotherapy to liquid biopsies to new research on side effects—here’s what to expect in 2019.
ASH 2018 conference highlights precision medicine, machine learning and gut microbiome.
Findings shed light on mechanisms that lead to liver cancer and for approaches to treat them.
Probiotics have been shown to help with long-term symptom management for cancer patients following treatment.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.